In AD patients, the overexpression of adenosine A2A receptor gene (ADORA2A) is aggravated (Horgusluoglu-Moloch et al., 2017) which can lead to decreased ability of astrocytes to clear the extracellular glutamate (Matos et al., 2012). This evidence concerns the gene ADORA2A and Alzheimer disease.